Market Tracker

06/23 5:16pm ET

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

18.15
Delayed Data
As of Jun 23
 +0.20 / +1.11%
Today’s Change
9.66
Today|||52-Week Range
19.90
+20.60%
Year-to-Date

Today’s Trading

Previous close17.95
Today’s open17.80
Day’s range17.65 - 18.15
Volume1,611,217
Average volume (3 months)861,653
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+76.52%
Earnings growth (this year)-365.97%
Earnings growth (next 5 years)--
Revenue growth (last year)+22.27%
P/E ratioNM
Price/Sales9.43
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
XLRNAcceleron Pharma Inc+0.15+0.44%
FPRXFive Prime Therapeut...-0.22-0.70%
EPZMEpizyme Inc+1.05+7.69%
CHRSCoherus BioSciences ...-0.15-0.95%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$109.6M
Annual profit (last year)-$21.0M
Net profit margin-19.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Financial Officer &
Senior Vice President
Scott M. Storer
Corporate headquarters
Cambridge, Massachusetts

Forecasts